Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Alternative therapies for Clostridium difficile infections.

Venuto C, Butler M, Ashley ED, Brown J.

Pharmacotherapy. 2010 Dec;30(12):1266-78. doi: 10.1592/phco.30.12.1266. Review.

PMID:
21114394
2.

Best strategies in recurrent or persistent Clostridium difficile infection.

Cocanour CS.

Surg Infect (Larchmt). 2011 Jun;12(3):235-9. doi: 10.1089/sur.2010.080. Epub 2011 Jul 18. Review.

PMID:
21767157
3.

Past, present, and future therapies for Clostridium difficile-associated disease.

Surowiec D, Kuyumjian AG, Wynd MA, Cicogna CE.

Ann Pharmacother. 2006 Dec;40(12):2155-63. Epub 2006 Dec 5. Review.

PMID:
17148650
4.

Fidaxomicin: a macrocyclic antibiotic for the management of Clostridium difficile infection.

Sullivan KM, Spooner LM.

Ann Pharmacother. 2010 Feb;44(2):352-9. doi: 10.1345/aph.1M351. Epub 2010 Jan 13. Review.

PMID:
20071495
5.

Clostridium difficile infection in older adults: a review and update on its management.

Kee VR.

Am J Geriatr Pharmacother. 2012 Feb;10(1):14-24. doi: 10.1016/j.amjopharm.2011.12.004. Epub 2012 Jan 20. Review.

PMID:
22260856
6.

Fidaxomicin for the treatment of Clostridium difficile infections.

Whitman CB, Czosnowski QA.

Ann Pharmacother. 2012 Feb;46(2):219-28. doi: 10.1345/aph.1Q481. Epub 2012 Feb 7. Review.

PMID:
22318930
7.

Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.

Miller M.

Expert Opin Pharmacother. 2010 Jun;11(9):1569-78. doi: 10.1517/14656566.2010.485614. Review.

PMID:
20446864
8.

Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.

Cheng AC, Ferguson JK, Richards MJ, Robson JM, Gilbert GL, McGregor A, Roberts S, Korman TM, Riley TV; Australasian Society for Infections Diseases..

Med J Aust. 2011 Apr 4;194(7):353-8.

PMID:
21470086
9.

Review article: treatment of Clostridium difficile infection.

Zimmerman MJ, Bak A, Sutherland LR.

Aliment Pharmacol Ther. 1997 Dec;11(6):1003-12.

10.

Clostridium difficile: controversies and approaches to management.

Bauer MP, van Dissel JT, Kuijper EJ.

Curr Opin Infect Dis. 2009 Dec;22(6):517-24. doi: 10.1097/QCO.0b013e32833229ce. Review.

PMID:
19738464
11.

Treatment strategies for C. difficile associated diarrhea.

Stepan C, Surawicz CM.

Acta Gastroenterol Latinoam. 2007 Sep;37(3):183-91. Review.

PMID:
17955730
12.

Comparative effectiveness of Clostridium difficile treatments: a systematic review.

Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, Wilt TJ.

Ann Intern Med. 2011 Dec 20;155(12):839-47. doi: 10.7326/0003-4819-155-12-201112200-00007. Review.

PMID:
22184691
13.

Probiotics for Clostridium difficile-associated diarrhea: focus on Lactobacillus rhamnosus GG and Saccharomyces boulardii.

Segarra-Newnham M.

Ann Pharmacother. 2007 Jul;41(7):1212-21. Epub 2007 Jun 26. Review.

PMID:
17595306
14.

Clinical manifestations, treatment and control of infections caused by Clostridium difficile.

Bouza E, Muñoz P, Alonso R.

Clin Microbiol Infect. 2005 Jul;11 Suppl 4:57-64. Review.

PMID:
15997485
15.

A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin.

Tannock GW, Munro K, Taylor C, Lawley B, Young W, Byrne B, Emery J, Louie T.

Microbiology. 2010 Nov;156(Pt 11):3354-9. doi: 10.1099/mic.0.042010-0. Epub 2010 Aug 19.

PMID:
20724385
16.

Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea.

Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W.

Clin Infect Dis. 1996 May;22(5):813-8. Erratum in: Clin Infect Dis 1996 Aug;23(2):423.

PMID:
8722937
17.

Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.

Musgrave CR, Bookstaver PB, Sutton SS, Miller AD.

Int J Infect Dis. 2011 Jul;15(7):e438-48. doi: 10.1016/j.ijid.2011.03.017. Epub 2011 May 18. Review.

18.

Current and future treatment modalities for Clostridium difficile-associated disease.

Halsey J.

Am J Health Syst Pharm. 2008 Apr 15;65(8):705-15. doi: 10.2146/ajhp070077. Review. Erratum in: Am J Health Syst Pharm. 2008 Jun 1;65(11):998.

PMID:
18387898
19.

Is there a future for probiotics in preventing Clostridium difficile-associated disease and treatment of recurrent episodes?

Imhoff A, Karpa K.

Nutr Clin Pract. 2009 Feb-Mar;24(1):15-32. doi: 10.1177/0884533608329232. Review.

PMID:
19244145
20.

Probiotics for Clostridium difficile diarrhea: putting it into perspective.

Karpa KD.

Ann Pharmacother. 2007 Jul;41(7):1284-7. Epub 2007 Jun 26.

PMID:
17595302

Supplemental Content

Support Center